New focus for UK's assistive technologies market
This article was originally published in Clinica
The devices directorate of the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has established a Centre for Assistive Technology (CAT), in a bid to centralise and improve standards of care in this area. From today, April 3, the Blackpool-based CAT will replace the MHRA's Wheeled Mobility and Seating Centre, and will be responsible for activities performed across two units.
You may also be interested in...
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.
Novo Nordisk’s CEO talks to Scrip about the promise of glucose-responsive insulin, stem cell therapy, and a diabetes landscape without Sanofi.